These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4547092)

  • 1. [Scleroderma in children (author's transl)].
    Posternak F; Orusco M
    Schweiz Rundsch Med Prax; 1974 Jul; 63(30):913-21. PubMed ID: 4547092
    [No Abstract]   [Full Text] [Related]  

  • 2. [Antinuclear antibodies in mesenchymal scleroderma and progressive systemic sclerosis (author's transl)].
    Sugiura M; Hashimoto T; Kurihara S; Nishikawa T; Hatano H
    Nihon Hifuka Gakkai Zasshi; 1980 Sep; 90(10):935-7. PubMed ID: 7012401
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunofluorescent studies in patients with scleroderma and in their families].
    Szczepański A
    Przegl Dermatol; 1972; 59(6):727-32. PubMed ID: 4566145
    [No Abstract]   [Full Text] [Related]  

  • 4. [Radiochemical demonstration of serum antibodies against double stranded DNA in progressive and circumscribed scleroderma].
    Meffert H; Falck P; Sönnichsen N
    Dermatol Wochenschr; 1975 Sep; 161(9):771-2. PubMed ID: 1081055
    [No Abstract]   [Full Text] [Related]  

  • 5. [Scleroderma in plaques. Immunological and visceral disturbances (author's transl)].
    Bourgeois-Droin C; Touraine R
    Ann Med Interne (Paris); 1978 Feb; 129(2):107-12. PubMed ID: 305741
    [No Abstract]   [Full Text] [Related]  

  • 6. [Localized scleroderma and PSS specific anti-Og antibody (author's transl)].
    Nishikawa T; Kurihara S; Sugiura M; Shimizu H; Tojo T
    Nihon Hifuka Gakkai Zasshi; 1981 Jul; 91(8):859-60. PubMed ID: 6976462
    [No Abstract]   [Full Text] [Related]  

  • 7. [Indications of the systemic character of circumscript scleroderma in children and adolescents].
    Albrecht-Nebe H; Eggert W; Ziegler H; Barthelmes H; Wolf S
    Dermatol Monatsschr; 1987; 173(3):123-30. PubMed ID: 3496247
    [No Abstract]   [Full Text] [Related]  

  • 8. Antinuclear antibodies in localized scleroderma.
    Takehara K; Moroi Y; Nakabayashi Y; Ishibashi Y
    Arthritis Rheum; 1983 May; 26(5):612-6. PubMed ID: 6405756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Types of anticellular structure antisera in scleroderma patients].
    Ni ZM
    Zhonghua Yi Xue Za Zhi; 1993 May; 73(5):270-2, 318. PubMed ID: 8221243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinuclear antibodies in children with localized scleroderma.
    Rosenberg AM; Uziel Y; Krafchik BR; Hauta SA; Prokopchuk PA; Silverman ED; Laxer RM
    J Rheumatol; 1995 Dec; 22(12):2337-43. PubMed ID: 8835572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Scleroderma, an ageing process? I. Clinical and immunological aspects (author's transl)].
    Sandhofer M; Fritz J; Altmann H
    Aktuelle Gerontol; 1977 Dec; 7(12):645-51. PubMed ID: 26229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proceedings: Serologic abnormalities and their significance in localized scleroderma.
    Scarola JA; Shulman LE
    Arthritis Rheum; 1975; 18(5):526. PubMed ID: 1081397
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunological studies in childhood scleroderma.
    Stögmann W; Sandhofer M; Fritz J
    Eur J Pediatr; 1977 Feb; 124(3):223-30. PubMed ID: 300058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Demonstration of antinuclear factors using indirect immunofluorescence in scleroderma patients].
    Nebe H; Blume N
    Dermatol Monatsschr; 1971 Jan; 157(1):27-31. PubMed ID: 4938251
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies in childhood scleroderma.
    Bernstein RM; Pereira RS; Holden AJ; Black CM; Howard A; Ansell BM
    Ann Rheum Dis; 1985 Aug; 44(8):503-6. PubMed ID: 3875322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localized scleroderma-like lesions induced by the Köbner phenomenon in a patient with systemic sclerosis positive for anticentromere antibody.
    Asano Y; Sato S
    Eur J Dermatol; 2020 Aug; 30(4):431-432. PubMed ID: 32808595
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antinuclear antibodies in localized scleroderma].
    Takehara K; Nakabayashi Y; Ishibashi Y; Moroi Y
    Nihon Hifuka Gakkai Zasshi; 1982; 92(8):883-8. PubMed ID: 6816966
    [No Abstract]   [Full Text] [Related]  

  • 18. [Significance of anti-centromere antibodies. Clinical value].
    Meyer O; Haim T; Ryckewaert A
    Rev Rhum Mal Osteoartic; 1983 Apr; 50(4):261-6. PubMed ID: 6348931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum proteins in sclerodermia (author's transl)].
    Kobíková M; Fucíková T; Stáva Z
    Cesk Dermatol; 1980 Oct; 55(5):295-300. PubMed ID: 7261076
    [No Abstract]   [Full Text] [Related]  

  • 20. [Circulating immune complexes in progressive systemic scleroderma and morphea].
    Yotsumoto H; Shimokawa Y; Hisadome H; Tashiro M
    Nihon Hifuka Gakkai Zasshi; 1983 May; 93(6):579-83. PubMed ID: 6620628
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.